Figure 7. Analysis of the JAK1 expression and immune cells proportion in LUAD cell lines with SARS-CoV-2 infection. (A) JAK1 expression in A549 cells and A549 cells with SARS-CoV-2 infection in GSE147507. (B) JAK1 expression in Calu3 cells and Calu3 cells with SARS-CoV-2 infection. (C) Proportions of the 22 tumor-infiltrating immune cell types in A549 cells with and without SARS-CoV-2 infection. (D) Proportions of the 22 tumor-infiltrating immune cell types in Calu3 cells with and without SARS-CoV-2 infection.